Researcher.Life Logo

Diabetologia : Impact Factor & More

eISSN: 1432-0428pISSN: 0012-186X

Key Metrics

CiteScore
16.6
H-Index
250
Impact Factor
5 - 10
Scite Index
0.87 5-Year SI
SJR
Q1Internal Medicine
SNIP
2.64
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Diabetologia

Diabetologia Journal Specifications

Overview
Publisher SPRINGER
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1965
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Diabetologia ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Diabetologia

Thromboxane signalling links immune activation to enhanced glucose uptake in skeletal muscle.
  • 1 Jun 2026
  • Diabetologia
Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage3 type 1 diabetes onset.
  • 1 Jun 2026
  • Diabetologia
Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
  • 1 Jun 2026
  • Diabetologia
Development and validation of a trans-ancestry polygenic risk score for type 1 diabetes.
  • 1 Jun 2026
  • Diabetologia
The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis in a mouse model of diabetes by enhancing GLP-1 secretion and Lcell differentiation.
  • 1 Jun 2026
  • Diabetologia
Association of corneal nerve parameters with nerve abnormalities and neuropathic pain in prediabetes and type 2 diabetes: the Maastricht Study.
  • 1 Jun 2026
  • Diabetologia
Thromboxane signalling links immune activation to enhanced glucose uptake in skeletal muscle.
  • 1 Jun 2026
  • Diabetologia
Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage3 type 1 diabetes onset.
  • 1 Jun 2026
  • Diabetologia
Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
  • 1 Jun 2026
  • Diabetologia
Development and validation of a trans-ancestry polygenic risk score for type 1 diabetes.
  • 1 Jun 2026
  • Diabetologia
The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis in a mouse model of diabetes by enhancing GLP-1 secretion and Lcell differentiation.
  • 1 Jun 2026
  • Diabetologia
Association of corneal nerve parameters with nerve abnormalities and neuropathic pain in prediabetes and type 2 diabetes: the Maastricht Study.
  • 1 Jun 2026
  • Diabetologia

FAQs on Diabetologia